Close Menu

University Health Network

Expression and copy number profiles from histologically normal duct tissue near tumors suggest a "field of cancerization" may exist in epithelial cells around cancer.

In Nucleic Acids Research this week: disease network resource, database of epigenetic consequences of de novo mutations, and more.

The initiatives are being funded with C$24 million over two years and will focus on acute leukemia, immuno-oncology, and brain, ovarian, and pancreatic cancer.

Researchers from the University Health Network in Toronto, the Mayo Clinic, Ohio State University, and University of Miami School of Medicine are among the early-access customers who have been using the product ahead of its commercial launch this week.

Thermo has expanded its collaboration with university partners, including George Mason's Lance Liotta and Emanuel Petricoin, to verify and validate protein biomarkers for cancer and other diseases.

The firm reported no revenues, but it managed to cut its net loss as it prepares to launch its LungExpress Dx product in the US later this year.

Med BioGene's CEO said the company is on track to launch its LungExpress assay in the second half of this year and will likely open a US office to support the test, which will initially be offered in a CLIA-compliant partner lab.

The expanded deal will provide Med Biogene with additional markers for its LungExpress Dx test.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.